NVZMY - Novozymes A/S

Other OTC - Other OTC Delayed Price. Currency in USD

Novozymes A/S

Krogshoejvej 36
Bagsvaerd 2880
Denmark
45 44 46 00 00
http://www.novozymes.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees6,442

Key Executives

NameTitlePayExercisedYear Born
Mr. Peder Holk NielsenPres & CEON/AN/A1956
Mr. Thomas VidebaekExectuive VP & COO of Research, Innovation & SupplyN/AN/A1960
Mr. Andrew FordyceExec. VP of Food & BeveragesN/AN/A1963
Mr. Anders LundExec. VP of Household Care & Technical IndustriesN/AN/A1973
Ms. Tina Sejersgård FanøExec. VP of Agriculture & BioenergyN/AN/A1969
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising bioscouring, bleach clean-up, desizing, denim finishing and abrasion, and biopolishing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rtrypsin for cell culture. Novozymes A/S has a strategic collaboration with Boehringer Ingelheim Animal Health for the research and development, production, marketing, and sale of a portfolio of probiotic products. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Corporate Governance

Novozymes A/S’s ISS Governance QualityScore as of July 29, 2019 is 6. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 10; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.